TrialBlood advances2023

Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.

Douglas E Gladstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.